Added to YB: 2021-05-30
Pitch date: 2021-05-30
OCGN [bearish]
Ocugen, Inc.
+83.75%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.
Market Cap
$193.3M
Pitch Price
$8.37
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.25
P/E
-3.32
EV/Sales
41.26
Sector
Biotechnology
Category
N/A
Show full summary:
OCUGEN INC OCGN
A summary for this pitch has not been created yet.
Read full article (0 min)